LGALS3 and Myocardial fibrosis: In patients with acute heart failure, a single-time-point-based measurement of plasma Gal-3 concentration and the severity of myocardial fibrosis are both predictors for the composite outcome of all-cause mortality and rehospitalization at 1-year follow-up.